37 Grants (Page 1 of 2)
2024
The mitochondrial genome in lung disease: a signaling hub linking the persistence and severity of inflammation to recovery
Audia, Jonathon P⋅GILLESPIE, MARK N and GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL169587-01A1), $652,078USD, 2024-03-15 -- 2028-02-29
2019
mtDNA damage and DAMPs in multiple organ dysfunction syndrome
GILLESPIE, MARK N
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1R01GM127823-01A1), $477,916USD, 2019-05-01 -- 2023-01-31
 
MtDNA repair: An isolated pharmacologic target in acute lung injury
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL113614-07), $418,430USD, 2012-04-16 -- 2022-06-30
2018
DNA Lesions and Gene Expression in Hypoxic Lung Disease
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL058234-17), $378,750USD, 1998-09-30 -- 2019-05-31
 
MtDNA repair: An isolated pharmacologic target in acute lung injury
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL113614-06A1), $454,751USD, 2012-04-16 -- 2022-06-30
2017
DNA Lesions and Gene Expression in Hypoxic Lung Disease
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL058234-16), $378,750USD, 1998-09-30 -- 2019-05-31
 
Mitochondrial DNA repair agents for acute lung injury
GILLESPIE, MARK N and WILSON, GLENN (contact)
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R44HL114225-03), $1,538,412USD, 2012-07-15 -- 2019-01-31
2016
DNA Lesions and Gene Expression in Hypoxic Lung Disease
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL058234-15), $378,750USD, 1998-09-30 -- 2019-05-31
 
MtDNA repair: An isolated pharmacologic target in acute lung injury
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 4R01HL113614-05), $371,250USD, 04/16/2012 -- 02/28/2017
2015
DNA Lesions and Gene Expression in Hypoxic Lung Disease
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL058234-14A1), $378,438USD, 1998-09-30 -- 2019-05-31
 
Mitochondrial DNA repair agents for acute lung injury
GILLESPIE, MARK N and WILSON, GLENN (contact)
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R44HL114225-02), $1,657,860USD, 2012-07-15 -- 2017-01-31
 
MtDNA repair: An isolated pharmacologic target in acute lung injury
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL113614-04), $365,681USD, 04/16/2012 -- 02/29/2016
2014
MtDNA repair: An isolated pharmacologic target in acute lung injury
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL113614-03), $363,825USD, 04/16/2012 -- 02/28/2017
2013
MtDNA repair: An isolated pharmacologic target in acute lung injury
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL113614-02), $353,430USD, 04/16/2012 -- 02/28/2017
2012
MtDNA repair: An isolated pharmacologic target in acute lung injury
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL113614-01), $371,250USD, 04/16/2012 -- 02/28/2017
2009
Lung Cell Genomic Threats from Physiological Signals
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL073244-05), $346,086USD, 04/01/2005 -- 03/31/2011
2008
Lung Cell Genomic Threats from Physiological Signals
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL073244-04), $346,086USD, 04/01/2005 -- 03/31/2010
2007
Lung Cell Genomic Threats from Physiological Signals
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL073244-03), $346,086USD, 04/01/2005 -- 03/31/2010
2006
Lung Cell Genomic Threats from Physiological Signals
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL073244-02), $356,423USD, 04/01/2005 -- 03/31/2010
2005
Lung Cell Genomic Threats from Physiological Signals
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL073244-01A2), $365,000USD, 04/01/2005 -- 03/31/2010
1999
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-12), 12/20/1990 -- 06/30/2001
1998
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-11), 12/20/1990 -- 06/30/2000
1997
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-10), 12/20/1990 -- 06/30/2000
1996
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL038495-09), 12/20/1990 -- 06/30/2000
1995
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 7R01HL038495-08), 12/20/1990 -- 06/30/1996